Ata uhi

Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice

Among the vinca-alkaloid class, vincristine is a potent chemotherapeutic agent with significant neurotoxic effects and is employed to address a wide spectrum of cancer types. Recently, the therapeutic potential of the cholecystokinin type 2 receptor (CCK2R) as a target for vincristine-induced periph...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Amandine Bernard (Author), Mohamad Mroué (Author), Sylvie Bourthoumieu (Author), Malcolm Boyce (Author), Laurence Richard (Author), Franck Sturtz (Author), Claire Demiot (Author), Aurore Danigo (Author)
Hōputu:	Pukapuka
I whakaputaina:	MDPI AG, 2024-01-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice
mā: Amandine Bernard, me ētahi atu.
I whakaputaina: (2022)

The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
mā: Amandine Bernard, me ētahi atu.
I whakaputaina: (2021)

Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy
mā: Mohamad Mroué, me ētahi atu.
I whakaputaina: (2024)

Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
mā: Hichem Bouchenaki, me ētahi atu.
I whakaputaina: (2022)

The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
mā: Aurore Danigo, me ētahi atu.
I whakaputaina: (2021)

Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice
mā: Hichem Bouchenaki, me ētahi atu.
I whakaputaina: (2021)

Peripheral Neuropathy in Patients with Acute Leukemia Treated with Vincristine
mā: Taslim E. Soetomenggolo
I whakaputaina: (2018)

Vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia
mā: Divya Tanwar, me ētahi atu.
I whakaputaina: (2024)

Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells
mā: Atsuko Funakoshi, me ētahi atu.
I whakaputaina: (2022)

The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial
mā: Victor Ciofoaia, me ētahi atu.
I whakaputaina: (2024)

Hydroethanolic extract of Lavandula angustifolia ameliorates vincristine-induced peripheral neuropathy in rats
mā: Shamim Sahranavard, me ētahi atu.
I whakaputaina: (2022)

Through Its Powerful Antioxidative Properties, L-Theanine Ameliorates Vincristine-Induced Neuropathy in Rats
mā: Chih-Chuan Yang, me ētahi atu.
I whakaputaina: (2023)

Hydroethanolic Stem Bark Extract of Burkea africana Attenuates Vincristine-Induced Peripheral Neuropathy in Rats
mā: Yakubu Jibira, me ētahi atu.
I whakaputaina: (2020)

Hereditary Motor and Sensory Neuropathies
mā: J Gordon Millichap
I whakaputaina: (1990)

Pyridoxine-Induced Sensory Neuropathy
mā: J Gordon Millichap
I whakaputaina: (1995)

Potentiation of PIEZO2 mechanically-activated currents in sensory neurons mediates vincristine-induced mechanical hypersensitivity
mā: Mingli Duan, me ētahi atu.
I whakaputaina: (2023)

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
mā: Qing-Yan Yang, me ētahi atu.
I whakaputaina: (2021)

Hereditary Motor and Sensory Neuropathy IIB
mā: J Gordon Millichap
I whakaputaina: (1997)

Hereditary Motor and Sensory Neuropathy (HMSN)
mā: J Gordon Millichap
I whakaputaina: (1987)

Hereditary Motor and Sensory Neuropathy Mutation
mā: J Gordon Millichap
I whakaputaina: (1992)

Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
mā: Barthelemy Diouf, me ētahi atu.
I whakaputaina: (2021)

Genetics of Motor and Sensory Neuropathy Type 2C
mā: J Gordon Millichap
I whakaputaina: (2000)

Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum
mā: J Gordon Millichap
I whakaputaina: (2003)

Sensory neuropathy and nociception in rodent models of Parkinson's disease
mā: Lucie Valek, me ētahi atu.
I whakaputaina: (2019)

Vincristine-Induced Acrocyanosis and Erythema Pernio
mā: Hayden T. Middleton, me ētahi atu.
I whakaputaina: (2023)

Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8
mā: Takafumi Hayashi, me ētahi atu.
I whakaputaina: (2020)

Significance of the rs754635 variant of the cholecystokinin gene in the development of obesity in children
mā: A. Nikulina
I whakaputaina: (2023)

Painless ulcers and fissures of toes: Hereditary sensory neuropathy, not leprosy
mā: Angoori Gnaneshwar Rao
I whakaputaina: (2016)

Unexplained multi-sensory neuropathy syndrome in young Tanzanian adults
mā: Enica R. Massawe, me ētahi atu.
I whakaputaina: (2021)

Diabetic Neuropathy and the Sensory apparatus Meissner Corpuscle and Merkel cells
mā: Husnia I Marrif, me ētahi atu.
I whakaputaina: (2014)

Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
mā: Fen Yang, me ētahi atu.
I whakaputaina: (2018)

Cardiovascular Toxicity Induced by Chronic Vincristine Treatment
mā: Esperanza Herradón, me ētahi atu.
I whakaputaina: (2021)

Effects of galantamine on social interaction impairments in cholecystokinin receptor-2 overexpression mice
mā: Shota Tanase, me ētahi atu.
I whakaputaina: (2022)

Early onset hereditary sensory autonomic neuropathy type I and not leprosy
mā: Pande Sushil, me ētahi atu.
I whakaputaina: (2009)

A case report of hereditary sensory and autonomic neuropathy - Type IV
mā: Phaneendra Kumar Manipudi, me ētahi atu.
I whakaputaina: (2023)

Unilateral Trigeminal Sensory Neuropathy with Sjögren's Syndrome with Liver and Renal Impairment
mā: Kana Ozasa, me ētahi atu.
I whakaputaina: (2021)

Cholecystokinin Inhibits Inducible Nitric Oxide Synthase Expression by Lipopolysaccharide-Stimulated Peritoneal Macrophages
mā: Rafael Simone Saia, me ētahi atu.
I whakaputaina: (2014)

Development and characteristics of novel sonosensitive liposomes for vincristine bitartrate
mā: Wen Lin, me ētahi atu.
I whakaputaina: (2019)

Hereditary sensory and autonomic neuropathy type V: Report of a rare case
mā: Ritesh Kalaskar, me ētahi atu.
I whakaputaina: (2015)

Case report: Hereditary sensory autonomic neuropathy presenting as bifid deformity to the tongue
mā: Kelsey O'Hagan-Wong, me ētahi atu.
I whakaputaina: (2023)